FDA created 21 CFR 874.6010 on November 6, a Class II regulation for external mechanical stimulators that relieve congestion. The rule codifies the De Novo the agency granted Sound Health Systems on December 4, 2023 for Sonu, a headband that delivers vibration to the sinus and nasal areas. The request, DEN230045, came in on June 16, 2023. The docket is FDA-2026-N-12125.

Six special controls travel with the classification. They require non-clinical performance testing that verifies the mechanical stimulation parameters, data on electromagnetic compatibility and battery and electrical safety, software verification and validation with hazard analysis, biocompatibility for patient-contacting components, human factors testing showing users can run the device from the labeling alone, and labeling that states frequency range, maximum output power, power source and an explanation of the user interface.

The codification is what opens the predicate. A second company building a vibratory congestion device can now file a 510(k) against product code QZC instead of requesting its own De Novo, which cuts a year and a fee tier off the plan. Sound Health already used the pathway on itself, clearing a follow-on Sonu under K242214 in April 2025.